We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




New Imaging Method Superior for Diagnosing Multiple Types of Cancer

By MedImaging International staff writers
Posted on 30 May 2023
Print article
Image: New imaging method offers potential for diagnosing, staging, and treating multiple types of cancer (Photo courtesy of SNMMI)
Image: New imaging method offers potential for diagnosing, staging, and treating multiple types of cancer (Photo courtesy of SNMMI)

Cancer-associated fibroblasts play a significant role in tumor development, migration, and progression. A subset of these fibroblasts expresses fibroblast activation protein (FAP), a protein prominently found in solid tumors but hardly present in healthy tissues. This makes FAP an appealing target for diagnosis and treatment using fibroblast activation protein inhibitors (FAPI). Now, two new studies have highlighted the potential of a novel FAPI radiotracer in the diagnosis, staging, and treatment of various types of cancer. The most comprehensive patient study of 68Ga-FAPI PET to date has demonstrated its superiority over the standard 18F-FDG PET in evaluating numerous cancers. Additionally, a newly developed FAPI-targeted treatment has demonstrated its ability to curb tumor growth in common cancers in preclinical trials. These advancements hold great promise for providing more accurate staging and management of cancer patients.

In the first study conducted by researchers at Essen University Hospital (Essen, Germany), 324 patients with 21 different types of tumors underwent 68Ga-FAPI PET over a span of three years; 237 of them also received 18F-FDG PET imaging. Researchers compared the uptake of 68Ga-FAPI PET and 18F-FDG PET across various tumors. They also looked for a potential correlation between 68Ga-FAPI uptake on PET scans and FAP expression in stained tissue samples. The uptake was significantly higher for 68Ga-FAPI compared to 18F-FDG in primary pancreatic cancer lesions and sarcoma, as well as in metastatic pancreatic cancer lesions. 68Ga-FAPI PET proved superior in detecting local, regional, and distant metastatic disease in various cancers, including sarcoma, pancreatic, head and neck, bile duct, lung, and bladder cancers. A positive correlation was also discovered between radiotracer uptake and FAP expression levels in tissue samples.

“68Ga-FAPI PET can be used as a tool for diagnosis of tumors, with the potential for more precise staging and management of patients with the aforementioned tumor entities,” said Nader Hirmas, MD, ScD, a PhD candidate at the Department of Nuclear Medicine at Essen University Hospital. “It could also be used as a tool to screen patients who would potentially benefit from FAP-directed radioligand therapy.”

In the second study, researchers at Purdue University (West Lafayette, IN, USA) developed a new FAP-targeted radiopharmaceutical therapy that targets naturally occurring cancer-associated fibroblasts. Using modern bioanalytical methods, they identified which cells in 34 human tumors of the breast, ovary, colon, and lung expressed FAP. They developed and tested two radiopharmaceutical conjugates, FAP6-DOTA and FAP6-IP-DOTA (the latter contains an albumin-binder for longer circulation and improved tumor uptake), on human cells expressing FAP. Additionally, radiopharmaceutical therapies of 177Lu-FAP6-DOTA and 177Lu-FAP6-IP-DOTA were evaluated in a mouse model. FAP was found to be over-expressed in 5% of human tumor cells, with cancer-associated fibroblasts making up 77% of this FAP-subpopulation and cancer cells constituting 2%. FAP6-IP-DOTA demonstrated high FAP affinity, extended circulation, increased tumor uptake, and minimal retention in healthy tissue. Additionally, single doses of 177Lu-FAP6-IP-DOTA curbed tumor growth by almost 50% in all tested tumor models without causing reproducible toxicities.

“These data suggest that this newly designed FAP-targeted radiotherapy should be capable of treating many more types of human cancers in which the FAP expression is limited to only the cancer-associated fibroblasts,” noted Spencer D. Lindeman, PhD, visiting scholar in the Department of Chemistry at Purdue University. “This could be a powerful and versatile tool for the field of clinical nuclear medicine.”

Related Links:
Essen University Hospital 
Purdue University

Gold Supplier
Conductive Gel
Tensive
Gold Supplier
128 Slice CT Scanner
Supria 128
New
Ultrasound Doppler System
BT-220
New
Portable DR Flat Panel Detector
VIVIX-S 1012N

Print article
Sun Nuclear -    Mirion

Channels

MRI

view channel
Image: Embrace is the first FDA 510(k) cleared and CE marked dedicated neonatal MRI system (Photo courtesy of Aspect Imaging)

Point of Care Neonatal MRI System Offers Transformative Solution for Neuroimaing Inside NICU

Magnetic resonance imaging (MRI) offers invaluable insights for neonatologists, but its application has been restricted in Neonatal Intensive Care Units (NICU) due to the precarious health condition of many infants.... Read more

Ultrasound

view channel
Image: FloPatch is a revolutionary tool that facilitates real-time precision in IV fluid management in sepsis (Photo courtesy of Flosonics)

Wireless, Wearable Doppler Ultrasound Revolutionizes Precision Fluid Management in Sepsis Care

When a patient comes to the hospital with sepsis, administering intravenous (IV) fluids is usually the first course of action. However, too much IV fluid can do more harm than good, causing additional... Read more

General/Advanced Imaging

view channel
Image: The AI software improves endovascular thrombectomy treatment times for stroke patients (Photo courtesy of 123RF)

AI Detects LVO from CT Angiograms to Improve Endovascular Thrombectomy Treatment Times for Stroke Patients

Large vessel occlusion (LVO) happens when a key artery in the brain gets blocked, and it's considered a particularly serious form of stroke. LVOs make up an estimated 24% to 46% of acute ischemic strokes.... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The Zenition 70 mobile C-arm with flat detector (Photo courtesy of Philips)

Global Fixed and Mobile C-Arms Market Driven by Increasing Surgical Procedures

The evolution of C-arm technology has been truly remarkable, ushering in the era of mobile and mini C-arms. These advancements have provided surgeons with the gift of mobility and improved image quality,... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.